董事会补选
Search documents
浙文互联集团股份有限公司第十一届董事会第四次临时会议决议公告
Shang Hai Zheng Quan Bao· 2025-12-15 20:09
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 浙文互联集团股份有限公司(以下简称"浙文互联"或"公司")第十一届董事会第四次临时会议通知于 2025年12月8日以邮件方式发出,本次会议于2025年12月15日在公司会议室以现场加通讯方式召开。会 议应出席董事7名,实际出席董事7名;会议由董事长尤匡领先生主持,公司高级管理人员列席了会议。 会议的召集和召开符合有关法律、行政法规、部门规章、规范性文件和公司章程的规定。 会议审议情况如下: 一、审议通过《关于补选第十一届董事会专门委员会成员的议案》 证券代码:600986 证券简称:浙文互联 公告编号:临2025-058 浙文互联集团股份有限公司 第十一届董事会第四次临时会议 决议公告 根据《公司法》《公司章程》等相关规定,为保证公司董事会专门委员会的正常运行,拟补选罗亮先生 为董事会审计委员会、薪酬与考核委员会的成员,任期自本次董事会审议通过之日起至公司第十一届董 事会任期届满之日。 本次补选完成后,公司第十一届董事会各董事会专门委员会成员如下: 1、审计委员会:罗春华、金小刚 ...
启迪药业: 第十届董事会临时会议决议公告
Zheng Quan Zhi Xing· 2025-09-05 11:12
Group 1 - The company held a temporary board meeting where all five participating directors voted in favor of several key proposals [1][2][3] - The company plans to appoint Jiang Xin and Zhou Yanqi as non-independent directors, pending approval at the first temporary shareholders' meeting in 2025 [1][2] - The company intends to change its name to "Guhan Health Industry Group Co., Ltd." to better reflect its main business and enhance brand recognition [2][3] Group 2 - The company expects to engage in daily operational related transactions with its shareholder's affiliate, Hunan Hengchang Pharmaceutical Group Co., Ltd., with a total transaction amount not exceeding 50 million yuan in 2025 [2][3] - A temporary shareholders' meeting is scheduled for September 22, 2025, to discuss the aforementioned proposals [3][4] - All proposals from the board meeting require approval at the upcoming shareholders' meeting [4]
西安国际医学投资股份有限公司关于召开2025年第一次临时股东会的提示性公告
Shang Hai Zheng Quan Bao· 2025-09-03 22:48
Meeting Overview - The company will hold its first extraordinary general meeting of 2025 on September 8, 2025 [1][2] - The meeting will be convened by the board of directors and is compliant with relevant laws and regulations [1][10] Meeting Details - The meeting will take place at 2:45 PM on September 8, 2025, with network voting available throughout the day [2][3] - Shareholders can vote either in person or via online platforms provided by the Shenzhen Stock Exchange [4][16] Attendance and Registration - Shareholders registered by the close of business on September 3, 2025, are eligible to attend [5][6] - Registration for attendance can be done in person or through authorized representatives [12][13] Agenda Items - The meeting will include proposals for amending the company's articles of association and electing a non-independent director [15][10] - A special resolution requires approval from at least two-thirds of the voting rights present [10][11] Voting Procedures - Voting will be conducted through both physical attendance and online systems, with specific time slots for online voting [3][18] - All proposals are non-cumulative voting items, and the first valid vote will be considered in case of duplicate votes [17][19] Additional Information - The company will not cover travel expenses for attending shareholders [20] - Contact information for inquiries is provided, including phone and fax numbers [21]
东来技术: 2025年第一次临时股东会会议材料
Zheng Quan Zhi Xing· 2025-07-24 16:11
Core Viewpoint - The company is convening its first extraordinary general meeting of shareholders in 2025 to ensure the protection of shareholders' legal rights and maintain the order and efficiency of the meeting [1][2]. Meeting Details - The meeting is scheduled for July 31, 2025, at 13:30, located at the company's conference room in Shanghai [5]. - Voting will be conducted through a combination of on-site and online methods, with specific time slots for internet voting [5]. Meeting Agenda - The agenda includes sign-in, distribution of materials, and registration for speaking [6]. - The chairman will announce the number of attending shareholders and their voting rights before proceeding with the meeting [6]. Proposals for Consideration - Proposal 1: Election of a new non-independent director to replace the resigned director, with the candidate being Mao Xinyong [6][7]. - Proposal 2: Adjustment of the 2025 director remuneration plan, specifically for non-independent directors not holding executive positions, proposing a consultant allowance of RMB 100,000 per year [8]. - Proposal 3: Formulation and revision of certain internal governance systems, in compliance with relevant laws and regulations [9][10]. Additional Proposals - Several additional proposals regarding the management of various internal systems, including external guarantees, external investments, and fundraising management, are also set for discussion [10][11].